Mechanisms and Research Progress of Traditional Chinese Medicine in the Treatment of Allergic Rhinitis from the Perspective of Modern Medicine
DOI:
https://doi.org/10.71204/c4x4t363Keywords:
Allergic Rhinitis, Integrated Traditional Chinese and Western Medicine, Mechanism of ActionAbstract
This article conducts a systematic review of the biological mechanisms and research progress in traditional Chinese medicine (TCM) for treating allergic rhinitis (AR) from a modern medical perspective. Research indicates that TCM exerts systemic therapeutic effects through a multi-target, multi-level network, with core mechanisms focusing on five key areas: first, the regulation of intestinal microecology, reshaping gut microbiota composition and metabolites based on the “gut-nose axis” theory; second, the repair of the mucosal barrier, protecting nasal epithelial cells by modulating programmed cell death pathways such as pyroptosis, autophagy, and ferroptosis; third, the restoration of immune homeostasis, correcting Th1/Th2 and Th17/Treg imbalances and inhibiting IgE-mediated cascade reactions; fourth, the modulation of inflammatory signaling pathways, including TLRs, NF-κB, and MAPK; and fifth, neuro-immune regulation, suppressing neuropeptide release and neurogenic inflammation. Current evidence suggests that TCM offers the advantage of “constitutional regulation and prognosis improvement.” Its integration with conventional therapies can significantly lower AR recurrence rates and mitigate drug-related side effects. To address challenges like lack of standardization and mechanistic opacity in TCM research, this review proposes establishing an evidence-based, standardized diagnostic and therapeutic framework. Utilizing whole-genomics, network pharmacology, and artificial intelligence for precise subtyping and personalized treatment is recommended to advance the modernization and scientific development of TCM in AR management.
References
Bernstein, J. A., Bernstein, J. S., Makol, R., & Ward, S. (2024). Allergic rhinitis: A review. JAMA, 331(10), 866–877.
Bousquet, J., Anto, J. M., Bachert, C., Baiardini, I., Bosnic-Anticevich, S., Canonica, G. W., Melén, E., Palomares, O., Scadding, G. K., & Togias, A. (2020). Allergic rhinitis. Nature Reviews Disease Primers, 6(1), 95.
Cao, L., Chen, X., Guo, Y., & Feng, Y. (2025). Study on the mechanism of Mahuang Xixin Fuzi decoction in treating allergic rhinitis and prediction of its Q-markers based on network pharmacology and molecular docking. Chinese Medicine and Natural Products, 5(2), e115–e123.
Chai, K., Wang, W., Wang, H., Zhang, T., Zhou, J., Li, J., Yang, S., Qiao, C., Guo, X., & Zhang, X. (2025). Efficacy and safety of Biyuan Tongqiao granules in the treatment of allergic rhinitis: A meta-analysis of randomized controlled trials. Journal of Ethnopharmacology, 344, 119572.
Chang, W., He, Y., & Liu, L. (2025). RGS1 induces nasal epithelial barrier dysfunction in allergic rhinitis by modulating NF-κB/AQP5 axis. Cytotechnology, 77(5), 164.
Chen, J., Huang, D., Zuo, X., Chen, S., & Xian, X. (2020). Regulatory effect of modified Huangqi Guizhi Wuwu decoction on Th1/Th2 and Th17/Treg cellular immune imbalance in rats with allergic rhinitis. Journal of Guangzhou University of Traditional Chinese Medicine, 37(7), 1327–1331.
Chen, T., Dong, L., Wu, Y., Shen, T., Deng, Y., Li, F., & Tao, Z. (2025). Bavachinin alleviates allergic rhinitis by modulating gut microbiota and inhibiting NLRP3-mediated epithelial pyroptosis through PI3K/AKT/NF-κB signaling pathway. Cellular Signalling, 112026.
Chen, X., Zhong, X., Liang, H., Zhang, X., & Zhou, M. (2020). Effects of triptolide on the expression of TGF-β1 and IL-4 in nasal mucosa tissue of rats with allergic rhinitis. Electronic Journal of Clinical Medical Literature, 1–16.
Choi, B. Y., Han, M., Kwak, J. W., & Kim, T. H. (2021). Genetics and epigenetics in allergic rhinitis. Genes, 12(12), 2004.
Chun, M., Li, S., Rubin, H., & Yang, L. (2019). Research progress and mechanism of traditional Chinese medicine in the treatment of allergic rhinitis. Journal of Basic Chinese Medicine, 25(10), 1473–1476.
Cui, G., Li, M., Guo, W., Gao, M., Zhu, Q., & Liao, J. (2025). AI-driven network pharmacology: Multi-scale mechanisms of traditional Chinese medicine from molecular to patient analysis. Computational and Structural Biotechnology Journal, 27, 5087.
Ding, M., Wei, X., Liu, C., & Tan, X. (2024). Mahuang Fuzi Xixin decoction alleviates allergic rhinitis by inhibiting NLRP3/Caspase-1/GSDMD-N-mediated pyroptosis. Journal of Ethnopharmacology, 327, 118041.
Dong, B., Xie, L., & Li, Y. (2025). Potential mechanisms of traditional Chinese medicine for the treatment of allergic rhinitis: Evidence from molecular and clinical studies. International Journal of General Medicine, 18, 5519–5555.
Dong, M., Chen, X., Xi, K., Wang, Y., Gui, Y., Zhang, F., Ma, C., Hong, H., Liu, X., & Jiang, Y. (2014). Effects of 18β-glycyrrhetinic acid on mitochondria in nasal mucosal epithelial cells of rats with allergic rhinitis. Journal of Otolaryngology and Ophthalmology of Shandong University, 28(3), 1–6.
Dong, Z. (2024). Multicenter clinical study of Yiqi Jiemin decoction in the treatment of moderate to severe allergic rhinitis (lung-spleen qi deficiency syndrome) [Master’s thesis, Beijing University of Chinese Medicine].
Du, Q., & Wang, X. (2024). Study on the effects of Linggui Zhugan decoction on nasal hypersecretion in rats with allergic rhinitis. Asia-Pacific Traditional Medicine, 20(6), 12.
Fan, Q., Qi, G., Wang, L., & Li, S. (2023). Clinical efficacy of self-made Yiqi Gufei Qufeng formula in the treatment of pediatric allergic rhinitis and its effect on Treg/Th17 balance. Journal of Sichuan of Traditional Chinese Medicine, 41(7), 166–169.
Fan, Y., Nguyen, T. V., Piao, C. H., Shin, H. S., Song, C. H., & Chai, O. H. (2022). Fructus Amomi extract attenuates nasal inflammation by restoring Th1/Th2 balance and down-regulation of NF-κB phosphorylation in OVA-induced allergic rhinitis. Bioscience Reports, 42(3), BSR20212681.
Fang, H., Min, D., & Zhang, H. (2024). Paeoniflorin inhibits IL-13-induced oxidative stress and autophagy in BEAS-2B cells via STAT3. Chinese Journal of Hospital Pharmacy, 44(13), 1535–1540.
Fei, Z., & Ying, T. (2022). Astragaloside IV treats allergic rhinitis in mice by balancing Th17/Treg cells and related cytokines. Journal of Shenyang Pharmaceutical University, 39(3), 277–282.
Fu, Q., & Zhang, Q. (2025). Interpretation of international guideline for clinical practice of Chinese medicine: Allergic rhinitis. Journal of Sichuan University (Medical Sciences), 56(4), 1027.
Gong, Z. (2018). Efficacy evaluation of intranasal acupuncture in the treatment of allergic rhinitis and exploration of its neuroimmunomodulatory mechanism [Master’s thesis, Beijing University of Chinese Medicine].
Greiner, A. N., Hellings, P. W., Rotiroti, G., & Scadding, G. K. (2011). Allergic rhinitis. The Lancet, 378(9809), 2112–2122.
Gu, J., Xu, X., Hou, J., Wang, B., & Liu, Y. (2025). Research progress on the mechanism of traditional Chinese medicine in the treatment of allergic rhinitis. Modern Journal of Integrated Traditional Chinese and Western Medicine, 34(17), 2450–2457.
Guo, L., Cong, P., Shen, Q., Xiong, G., & Ge, Y. (2014). Mechanism of Xinhuang decoction on histamine-induced in vitro allergic rhinitis mucosal tissue. Chinese Archives of Traditional Chinese Medicine, 32(5), 1183–1185.
He, X., Fan, H., Sun, M., Li, J., Xia, Q., Jiang, Y., & Liu, B. (2024). Structural analysis and immunomodulatory activity of a novel polysaccharide from Saposhnikoviae Radix. Chinese Traditional and Herbal Drugs, 55(4), 1089–1099.
He, X., Liu, L., Luo, X., Zhu, J., Yang, H., Wang, J., Chen, L., & Zhong, L. (2022). Astragalus polysaccharide relieves inflammatory responses in guinea pigs with allergic rhinitis via ameliorating NF-kB-mediated Treg/Th17 imbalance. American Journal of Rhinology & Allergy, 36(5), 638–648.
Hu, T., Dong, Y., Yang, C., Zhao, M., & He, Q. (2021). Pathogenesis of children’s allergic diseases: Refocusing the role of the gut microbiota. Frontiers in Physiology, 12, 749544.
Huang, S., Li, S., Chen, Z., & Peng, T. (2018). Effect of tanshinone IIA on mast cell-mediated allergic rhinitis by regulating the NF-κB pathway. Medical Journal of Wuhan University, 39(2), 223–227.
Jia, M., Zhang, S., Yu, Y., Xiao, S., Xiong, Y., & Han, G. (2022). Effects of Lu’e Biyan formula on Treg/Th17 cells and related cytokines in rats with allergic rhinitis. China Journal of Traditional Chinese Medicine and Pharmacy, 37(4), 1933–1937.
Jian, L., Xiao, C., He, Q., Li, H., Zhou, W., Xu, X., Wang, Y., & Zhu, H. (2017). Effects of honeysuckle extract on cytokine expression in mice with allergic rhinitis. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 46(3), 285–290.
Jin, Y., Zhu, Z., Wu, L., & Xuan, L. (2018). Effect of acupoint application on TLR-NF-κB signaling pathway in nasal mucosa tissue of allergic rhinitis model rats. Journal of Traditional Chinese Medicine, 59(12), 1054–1057.
Jung, M. A., Song, H. K., Jo, K., Lee, A., Hwang, Y. H., Ji, K. Y., Jung, D. H., Cai, M., Lee, J. Y., & Pyun, B. J. (2023). Gleditsia sinensis Lam. aqueous extract attenuates nasal inflammation in allergic rhinitis by inhibiting MUC5AC production through suppression of the STAT3/STAT6 pathway. Biomedicine & Pharmacotherapy, 161, 114482.
Kim, A. Y., Marduy, A., de Melo, P. S., Gianlorenco, A. C., Kim, C. K., Choi, H., Song, J. J., & Fregni, F. (2022). Safety of transcutaneous auricular vagus nerve stimulation (taVNS): A systematic review and meta-analysis. Scientific Reports, 12(1), 22055.
Kim, H. I., Kim, J. K., Kim, J. Y., Han, M. J., & Kim, D. H. (2019). Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression. Journal of Ginseng Research, 43(4), 635–644.
Kong, W., Han, D., Zhou, L., Xu, G., & Han, D. (2014). Otorhinolaryngology-Head and Neck Surgery. People’s Medical Publishing House.
Lee, D. Y., Li, Q. Y., Liu, J., & Efferth, T. (2021). Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis. Phytomedicine, 80, 153337.
Li, H., Wang, Y., & Han, X. (2023). ESP-B4 promotes nasal epithelial cell-derived extracellular vesicles containing miR-146a-5p to modulate Smad3/GATA-3 thus relieving allergic rhinitis. Phytomedicine, 108, 154516.
Li, Q., & Wei, Q. (2015). Clinical practice guideline for allergic rhinitis: Recommendations from the American Academy of Otolaryngology-Head and Neck Surgery. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 22(9), 482–486.
Li, S., Xu, D., Wang, Y., & Gao, F. (2024). Research progress on regulation of programmed cell death by traditional Chinese medicine in treatment of allergic rhinitis. Shanghai Journal of Traditional Chinese Medicine, 58(12), 189–194.
Li, Y., & Lu, Z. (2024). Study on the role of ephedrine in regulating Th2-type immune response by mediating TSLP/OX40L signaling pathway in rats with allergic rhinitis. Drugs & Clinic, 39(1), 14–22.
Li, Y., Liu, X., Zhou, J., Li, F., Wang, Y., & Liu, Q. (2025). Artificial intelligence in traditional Chinese medicine: Advances in multi-metabolite multi-target interaction modeling. Frontiers in Pharmacology, 16, 1541509.
Li, Y., Sun, L., & Zhang, Y. (2022). Programmed cell death in the epithelial cells of the nasal mucosa in allergic rhinitis. International Immunopharmacology, 112, 109252.
Li, Z., Jing, W., Wang, Y., Li, T., Chang, Y., & Wang, Y. (2025). Effect of Cang’er Wendan decoction on the TLR4/MyD88/NF-κB signaling pathway in rats with allergic rhinitis. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 31(6), 36–41.
Ma, C., Li, S., Hao, R., & Yang, L. (2019). Research progress and mechanism of traditional Chinese medicine in the treatment of allergic rhinitis. Journal of Basic Chinese Medicine, 25(10), 1473–1476.
Mao, Y., Liu, K., Jiang, W., Hu, N., Yu, J., Zhang, Y., & Zheng, J. (2021). Experimental study on the effect of Chuanxiong Baizhi on hemorheology and expression of inflammatory factors in allergic dermatitis model. Progress in Modern Biomedicine, 263.
Meihui, T., Yanan, Z., Weifang, S., Huan, L., & Yong, T. (2024). Mechanism of acupuncture at “sphenopalatine point” in improving immune inflammatory response in rats with allergic rhinitis based on TLR4/MyD88/NF-κB signaling pathway. Acupuncture Research, 49(5), 456–462.
Niu, M., Wu, H., Wang, Y., Li, R., Zhang, Y., Xu, Z., Qin, Y., Liu, H., Han, J., & Dong, S. (2025). Macrophage polarization and allergic rhinitis: A review. International Immunopharmacology, 164, 115334.
Nunez, H., Nieto, P. A., Mars, R. A., Ghavami, M., Sew Hoy, C., & Sukhum, K. (2025). Early life gut microbiome and its impact on childhood health and chronic conditions. Gut Microbes, 17(1), 2463567.
Nur Husna, S. M., Tan, H. T. T., Md Shukri, N., Mohd Ashari, N. S., & Wong, K. K. (2021). Nasal epithelial barrier integrity and tight junction disruption in allergic rhinitis: Overview and pathogenic insights. Frontiers in Immunology, 12, 663626.
Ren, J., Han, Y., Zhang, Z., Ren, A., Chen, Y., & Li, X. (2023). Study on the effects of Saposhnikovia polysaccharides on ethology, AQP5 and nasal mucosa tissue in allergic rhinitis rats based on NF-κB/STAT3 signaling pathway. Medical Journal of West China, 35(1), 39–45.
Salem, I., Ramser, A., Isham, N., & Ghannoum, M. A. (2018). The gut microbiome as a major regulator of the gut–skin axis. Frontiers in Microbiology, 9, 382698.
Seijo-Martinez, M., Varela-Freijanes, A., Grandes, J., & Vazquez, F. (2006). Sneeze-related area in the medulla: Localisation of the human sneezing centre? Journal of Neurology, Neurosurgery & Psychiatry, 77(4), 559–561.
Shao, L., & Zhang, B. (2013). Traditional Chinese medicine network pharmacology: Theory, methodology and application. Chinese Journal of Natural Medicines, 11(2), 110–120.
Shi, X., Gu, X., & Fu, X. (2024). Anti-inflammatory mechanism of Bimin formula in the treatment of allergic rhinitis based on Th17/IL-17A signaling pathway. Journal of Chinese Medicinal Materials, 47(4), 1016–1019.
Sun, S., Gu, X., Qian, P., Yu, X., Zheng, J., Zhao, Q., Li, J., & Hong, M. (2023). Systematic pharmacology-based exploration of the targets and mechanisms of Sanfeng Tongqiao dripping pills in the treatment of allergic rhinitis. Journal of Nanjing University of Traditional Chinese Medicine, 39(10), 999–1005.
Tian, M., Zhang, Y., Sun, W., Liu, H., & Tang, Y. (2024). Mechanism of acupuncture at “sphenopalatine point” in improving immune inflammatory response in rats with allergic rhinitis based on TLR4/MyD88/NF-κB signaling pathway. Acupuncture Research, 49(5), 456–462.
Tong, W., & Yan, L. (2025). Research progress in the treatment of allergic rhinitis with traditional Chinese medicine. Traditional Chinese Medicine, 14, 2211.
Wang, J., Feng, X., Li, T., Bi, Y., Zhang, T., Xu, H., Yu, G., Zhang, C., & Sun, Y. (2022). Preliminary study on potential compounds and mechanism of Chuanxiong Chatiao granules in treating migraine. Pharmacological Research – Modern Chinese Medicine, 4, 100134.
Wang, L., Fu, H., & Zhou, Z. (1999). Effect of Asarum and Fructus Xanthii on interferon induction in mice. Chinese Journal of Clinical Pharmacy, Suppl., 23–25.
Wang, M., Fu, L., Wang, H., & Tian, L. (2025). Hotspots and trends in allergic rhinitis nasal mucosa studies: A bibliometric analysis (2010–2024). Journal of Asthma and Allergy, 417–435.
Wang, N., Du, N., Peng, Y., Yang, K., Shu, Z., Chang, K., Wu, D., Yu, J., Jia, C., & Zhou, Y. (2021). Network patterns of herbal combinations in traditional Chinese clinical prescriptions. Frontiers in Pharmacology, 11, 590824.
Wang, R., Wang, Y., Yang, Q., Liu, J., Lu, Z., Xu, W., Zhu, J., Liu, H., He, W., & Yan, Y. (2024). Xiaoqinglong decoction improves allergic rhinitis by inhibiting NLRP3-mediated pyroptosis in BALB/C mice. Journal of Ethnopharmacology, 321, 117490.
Wang, S., Fu, Z., & Wu, X. (2024). Effect of Lycium barbarum polysaccharides on Th1/Th2 cytokines in mice with allergic rhinitis based on NF-κB signaling pathway. Modern Journal of Integrated Traditional Chinese and Western Medicine, 33(7), 928–932.
Wang, X., Liu, J., Tian, Q., Guo, W., Li, Y., Liu, C., Yang, C., & Ma, C. (2016). Research progress on the immunomodulatory effect of paeoniflorin on cellular immunity. Chinese Archives of Traditional Chinese Medicine, 34(6), 1306–1308.
Wang, X., Wu, M., Lai, X., Zheng, J., Hu, M., Li, Y., & Li, S. (2020). Network pharmacology to uncover the biological basis of spleen qi deficiency syndrome and herbal treatment. Oxidative Medicine and Cellular Longevity, 2020, 2974268.
Wang, Y., Yang, H., Chen, L., Jafari, M., & Tang, J. (2021). Network-based modeling of herb combinations in traditional Chinese medicine. Briefings in Bioinformatics, 22(5), bbab106.
Wang, Z., Liu, S., Li, S., Wei, F., Lu, X., Zhao, P., Sun, C., & Yao, J. (2025). Jingfang granules alleviate OVA-induced allergic rhinitis through regulating endoplasmic reticulum stress signaling pathway. Journal of Ethnopharmacology, 338, 119039.
Wei, X., Ding, M., Liang, X., Zhang, B., Tan, X., & Zheng, Z. (2023). Mahuang Fuzi Xixin decoction ameliorates allergic rhinitis and repairs the airway epithelial barrier by modulating lung microbiota dysbiosis. Frontiers in Microbiology, 14, 1206454.
Wu, J., Zhang, B., Zhang, Y., & Zhang, H. (2020). Potential biological mechanism and preliminary validation of Majie formula against allergic rhinitis based on network pharmacology. Journal of Beijing University of Traditional Chinese Medicine, 43(8), 12-19.
Wu, L., Liu, Y., & Wang, C. (2023). Clinical progress in the treatment of allergic rhinitis. Advances in Clinical Medicine, 13, 16256.
Xi, Y., He, X., & Liu, Y. (2023). Protective effect and mechanism of modified Yupingfeng nasal spray on nasal mucosal injury in AR model rats. China Pharmacy, 34(10), 1204–1210.
Xiao, Z., & Xu, J. (2025). Research progress on the mechanism of action of intranasal acupuncture in the treatment of allergic rhinitis. Guangming Journal of Chinese Medicine, 40(18), 4078–4081.
Xiao, Z., Deng, Q., Zhou, W., & Zhang, Y. (2022). Immune activities of polysaccharides isolated from Lycium barbarum L.: What do we know so far? Pharmacology & Therapeutics, 229, 107921.
Xie, W., Chen, H. G., Chen, R. H., Zhao, C., Gong, X. J., & Zhou, X. (2024). Intervention effect of Lycium barbarum polysaccharide on lead-induced kidney injury mice and its mechanism based on PI3K/Akt/mTOR signaling pathway. Journal of Ethnopharmacology, 319, 117197.
Xu, N., Hua, Y., Tan, X., Wang, J., Liang, Z., Zhou, S., Li, Y., Chen, W., Xia, J., & Luo, Q. (2024). Effects of Bimin formula on TMEM16A/NF-κB/MUC5AC signaling pathway in nasal mucosa of allergic rhinitis model rats with lung-spleen qi deficiency syndrome. Journal of Traditional Chinese Medicine, 65(8), 842–848.
Yan, D. (2021). Yan Daonan’s effective prescriptions and clinical experience—Yiqi Wenyang formula. Jiangsu Journal of Traditional Chinese Medicine, 53(8), 5–6.
Yan, J., Zhang, S., Xiao, S., Fan, J., Luo, X., & Jia, M. (2024). Effects of Lu’e Biyan formula on Th17/Treg in allergic rhinitis mice based on Notch1–Jagged1 signaling pathway. Chinese Journal of Integrated Traditional and Western Medicine, 44(5), 575–582.
Yan, Z., Jiao, L., Gong, Z., Liu, L., Liu, S., Liu, Q., Li, X., Zhang, Y., Bian, F., & Liu, J. (2018). Clinical observation on 60 cases of moderate–severe allergic rhinitis treated with intranasal acupuncture combined with Yiqi Jiemin decoction. Journal of Traditional Chinese Medicine, 59(12), 1035–1038.
Yang, M., Zhu, X., Fu, F., Guo, Q., Zhu, X., Xu, Y., Yan, X., He, X., & Wang, X. (2022). Baicalin ameliorates inflammatory response in a mouse model of rhinosinusitis via regulating the Treg/Th17 balance. Ear, Nose & Throat Journal, 101(2_suppl), 8S–16S.
Yang, Q., Sun, Y., An, J., Wang, L., Zhang, C., Fei, Y., Wu, K., Zhai, X., & Wu, Y. (2025). Xiaoqinglong decoction attenuates inflammatory response and mitochondrial injury via the TLR4/MyD88/NF-κB pathway in allergic rhinitis. International Archives of Allergy and Immunology, 186(10), 927–940.
Yu, N., Huang, J., Liu, J., Wang, S., Zhang, Y., Wu, F., & Yu, G. (2025). Development of a cold–heat syndrome classification model for children with allergic rhinitis based on multimodal data. Translational Pediatrics, 14(12), 3375–3386.
Yu, S., Qian, H., Tian, D., Yang, M., Li, D., Xu, H., Chen, J., Yang, J., Hao, X., & Liu, Z. (2023). Linggui Zhugan decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure. Frontiers in Pharmacology, 14, 1074837.
Zhang, F., & Tian, Y. (2022). Astragaloside IV treats allergic rhinitis in mice by balancing Th17/Treg cells and related cytokines. Journal of Shenyang Pharmaceutical University, 39(3), 277–282.
Zhang, Y., Li, J., Zhao, Y., Wang, C., & Zhang, L. (2019). Identification of rare variants of allergic rhinitis based on whole genome sequencing and gene expression profiling. World Allergy Organization Journal, 12(6), 100038.
Zhang, Y., Song, Y., Wang, C., Jiang, J., Liu, S., Bai, Q., Li, L., Jin, H., Jin, Y., & Yan, G. (2022). Panax notoginseng saponin R1 attenuates allergic rhinitis through AMPK/Drp1-mediated mitochondrial fission. Biochemical Pharmacology, 202, 115106.
Zhang, Y., Wu, N., & Wang, W. (2015). Morphological observation of the effects of modified licorice and dried ginger decoction on pharyngolaryngeal mucosa in allergic rhinitis rat models. Journal of Guizhou University of Traditional Chinese Medicine, 37(3), 9–12.
Zhou, Y., Peng, L., Zhang, Y., & Sun, X. (2024). Research progress on structural optimization and biological activities of triptolide. Chinese Pharmaceutical Journal, 59(19), 1795–1806.
Zhou, Y., Wang, Y., Zhang, Q., Hou, X., Zhou, K., & Li, L. (2024). Acupoint injection inhibits abnormal mucin secretion and nasal mucosal inflammatory response in allergic rhinitis rats via the p38 MAPK pathway. Acupuncture Research, 49(11), 1160–1167.
Zhu, H., Rong, P., Chen, Y., Song, X., & Wang, J. (2024). Possible mechanism of auricular point therapy for migraine via the auricular vagus nerve. Acupuncture Research, 49(4), 403–408.
Published
Issue
Section
License
Copyright (c) 2026 Ziyang Yu, Zhanfeng Yan (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are properly credited. Authors retain copyright of their work, and readers are free to copy, share, adapt, and build upon the material for any purpose, including commercial use, as long as appropriate attribution is given.